ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 780

$1.09M Total Retail Price of All Prescriptions

Rank: 53 out of 780

493 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 493 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

50% of this provider’s 493 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 13,874 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,975 938 S3 1 1
OMEPRAZOLE 696 457 2 3
METFORMIN HCL 568 377 3 8
SIMVASTATIN 550 351 4 2
AMLODIPINE BESYLATE 547 377 5 4
LISINOPRIL 483 326 6 6
CITALOPRAM HBR 457 289 7 23
CARISOPRODOL 451 50 R 8 67
FUROSEMIDE 408 274 9 7
LEVOTHYROXINE SODIUM 397 272 10 5
POTASSIUM CHLORIDE 349 238 11 11
METOPROLOL TARTRATE 346 197 12 19
ZOLPIDEM TARTRATE 330 205 13 17
OXYCODONE HCL 313 69 S2 14 123
DONEPEZIL HCL 307 305 15 31
GABAPENTIN 301 132 16 13
CARVEDILOL 299 201 17 14
CLONIDINE HCL 295 146 18 28
NEXIUM 249 87 19 22
PANTOPRAZOLE SODIUM 242 158 20 25
MELOXICAM 235 142 21 16
CLOPIDOGREL 232 141 22 34
NAMENDA 230 230 23 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 224 135 24 26
RAMIPRIL 220 146 25 70
WARFARIN SODIUM 206 164 26 24
LOSARTAN POTASSIUM 204 153 27 18
TRAZODONE HCL 197 88 28 35
PRAVASTATIN SODIUM 192 114 29 9
TRIAMTERENE-HCTZ 189 99 30 37
QUETIAPINE FUMARATE 181 131 31 81
TORSEMIDE 178 146 32 114
GLIMEPIRIDE 173 146 33 30
PROMETHAZINE HCL 168 53 R 34 66
TIZANIDINE HCL 163 70 35 82
BUMETANIDE 158 112 36 96
HYDRALAZINE HCL 155 119 37 54
KLOR-CON M20 147 138 38 57
CRESTOR 146 103 39 32
PLAVIX 140 75 40 45
FLUOXETINE HCL 138 64 41 65
ATENOLOL 136 108 42 21
MIRTAZAPINE 135 101 43 58
ATORVASTATIN CALCIUM 135 112 43 12
PAROXETINE HCL 134 81 45 69
PROAIR HFA 133 67 46 62
HYDROCHLOROTHIAZIDE 132 95 47 10
RANITIDINE HCL 127 65 48 39
DIGOXIN 127 102 48 56
AZITHROMYCIN 125 57 50 38
AMLODIPINE BESYLATE-BENAZEPRIL 120 79 51 50
METOPROLOL SUCCINATE 117 71 52 20
AMOXICILLIN 115 61 53 99
ESCITALOPRAM OXALATE 113 87 54 61
METHADONE HCL 109 19 S2 55 127
ISOSORBIDE MONONITRATE ER 108 77 56 60
CYMBALTA 106 51 57 51
SERTRALINE HCL 105 84 58 27
TRAMADOL HCL 105 96 58 15
AMPHETAMINE SALT COMBO 103 17 S2 60 201
CYCLOBENZAPRINE HCL 103 51 R 60 42
ENDOCET 102 20 S2 62 129
CELEBREX 102 73 62 89
VENTOLIN HFA 102 20 62 91
DIVALPROEX SODIUM 101 90 65 119
ALLOPURINOL 96 59 66 29
OXYCONTIN 93 39 S2 67 165
DICLOFENAC SODIUM 89 74 68 137
NABUMETONE 89 57 68 171
CARBIDOPA-LEVODOPA 87 40 70 124
ADVAIR DISKUS 86 42 71 68
LYRICA 78 47 72 52
PREDNISONE 77 40 73 40
FLUTICASONE PROPIONATE 75 49 74 41
IBUPROFEN 75 38 74 93
SPIRONOLACTONE 74 39 76 53
ALENDRONATE SODIUM 73 73 77 44
PREMARIN 73 45 R 77 110
OXYBUTYNIN CHLORIDE 72 65 79 148
LOVASTATIN 72 63 79 47
CIPROFLOXACIN HCL 71 53 81 49
THEOPHYLLINE ANHYDROUS 71 36 81 185
INSULIN SYRINGE 69 36 83 80
SEROQUEL 68 47 84 172
AMIODARONE HCL 67 41 85 139
EXELON 67 62 85 132
BUSPIRONE HCL 67 29 85 125
ALPRAZOLAM 66 50 88 328
BYSTOLIC 64 29 89 118
RISPERIDONE 63 45 90 98
DETROL LA 63 62 90 215
TAMSULOSIN HCL 63 53 90 36
HUMULIN 70-30 61 37 93 106
OXYCODONE HCL-ACETAMINOPHEN 59 18 S2 94 146
FLUCONAZOLE 59 19 94 111
VENLAFAXINE HCL ER 56 24 96 117
GLIPIZIDE 56 47 96 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 28 96 88
LEVETIRACETAM 55 19 99 130
ROPINIROLE HCL 55 48 99 87
AMITRIPTYLINE HCL 55 36 R 99 48
METOCLOPRAMIDE HCL 53 28 102 102
POLYETHYLENE GLYCOL 3350 52 34 103 79
METHOCARBAMOL 51 17 R 104 84
CILOSTAZOL 50 32 105 229
ACTOS 50 24 105 144
BENAZEPRIL HCL 50 24 105 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.